#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Skin pigmented lesions in the hands of an ambulatory surgeon


Authors: Ondřej Troup 1,2;  A. Růžičková 3;  A. Koy 3;  Vlastimil Woznica 1;  Inka Třešková 1,2
Authors‘ workplace: Oddělení plastické, chirurgie, FN Plzeň 1;  LF UK v Plzni 2;  Dermatovenerologická, klinika LF UK a FN Plzeň 3
Published in: Rozhl. Chir., 2024, roč. 103, č. 10, s. 381-386.
doi: https://doi.org/10.48095/ccrvch2024381

Overview

The ambulatory surgeon deals daily with patients who come for various pigmented skin lesions. A number of patients come on the recommendation of a dermatologist, but for the majority of patients, the primary visit is directly to the surgical clinic. The reason for removing a pigmented lesion may be an unsatisfactory cosmetic appearance or frequent irritation due to inappropriate location of the lesion, but also the fear of the development of malignancy. Pigmented lesions of the skin are a very hetero­geneous group represented from benign nevi to malignant melanoma. They occur in all age groups. Congenital nevi and hemangiomas are most often treated at an early age, and the incidence of skin malignancies increases in older patients. The ambulatory surgeon is often faced with the decision whether and how radically the pigmented lesion needs to be removed. Skin lesions such as lentigo solaris do not need to be treated surgically. Other lesions, such as basal cell carcinoma, require radical excision and subsequent professional dispensary. However, the treatment of melanoma is complex, it is led by specialists in dermato-oncology centers and therefore interdisciplinary approach is neces­sary. Every ambulatory surgeon should be knowledgeable and experienced enough to be able to decide on the need for removal of pigmented lesions and, in case of uncertainty, refer the patient to a skin specialist. This article provides a brief overview and specifics of basic skin pigment manifestations and criteria for their surgical removal.

Keywords:

melanoma – pigmented skin lesions – nevi


Sources
1.           Drodge DR, Staines K, Shipley D. Skin cancer – what general dental practitioners should look for. Br Dent J 2024; 236(4): 279–283. doi: 10.1038/s41415-024-7084-6.
2.           Abbasi NR, Shaw HM, Rigel DS et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004; 292(22): 2771–2776. doi: 10.1001/jama.292.22.2771.
3.           Pizinger K. Kožní pigmentové projevy. Praha: Grada Publishing 2003.
4.           Brychta P. Estetická plastická chirurgie a korektivní dermatologie. Praha: Grada Publishing 2014.
5.           Ortonne JP, Pandya AG, Lui H et al. Treatment of solar lentigines. J Am Acad Dermatol 2006; 54(5 Suppl 2): S262–271. doi: 10.1016/j.jaad.2005.12.043.
6.           Gutowski KA. Grabb & Smith’s plastic surgery. Plast Reconstr Surg 2007; 120(2): 570. doi: 10.1097/01.prs.0000238227.88345.ae.
7.           Shuber E, Abdulhussein D, Sinclair P et al. Who should carry out skin cancer excisions? A systematic review. J Cutan Aesthet Surg 2019; 12(3): 153–157. doi: 10.4103/JCAS.JCAS_174_18.
8.           Macneal P, Patel BC. Congenital melanocytic nevi. [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/33085315/.
9.           Navarro-Fernandez IN, Mahabal GD. Congenital nevus. [online]. Available from: https://pubmed.ncbi.nlm.nih.gov/32644696/.
10.         Mologousis MA, Tsai SY, Tissera KA et al. Updates in the management of congenital melanocytic nevi. Children (Basel) 2024; 11(1): 62. doi: 10.3390/children11010062.
11.         Isaak AJ, Clements GR, Buenaventura RGM et al. Development of personalized strategies for precisely battling malignant melanoma. Int J Mol Sci 2024; 25(9): 5023. doi: 10.3390/ijms25095023.
12.         Saginala K, Barsouk A, Aluru JS et al. Epidemiology of melanoma. Med Sci (Basel) 2021; 9(4): 63. doi: 10.3390/medsci9040063.
13.         Jones OT, Ranmuthu CKI, Hall PN et al. Recognising skin cancer in primary care. Adv Ther 2020; 37(1): 603–616. doi: 10.1007/s12325-019-01130-1.
14.         Garbe C, Amaral T, Peris K et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment – update 2022. Eur J Cancer 2022; 170: 256–284. doi: 10.1016/j.ejca.2022.04.018.
15.         Wollina U. Recent advances in managing and understanding seborrheic keratosis. F1000Res 2019; 8: F1000 Faculty Rev-1520. doi: 10.12688/f1000research.18983.1.
16.         Sun MD, Halpern AC. Advances in the etiology, detection, and clinical management of seborrheic keratoses. Dermatology 2022; 238(2): 205–217. doi: 10.1159/000517070.
17.         Moscarella E, Brancaccio G, Briatico G et al. Differential diagnosis and management on seborrheic keratosis in elderly patients. Clin Cosmet Investig Dermatol 2021; 14: 395–406. doi: 10.2147/CCID.S267246.
18.         Dika E, Scarfì F, Ferracin M et al. Basal cell carcinoma: a comprehensive review. Int J Mol Sci 2020; 21(15): 5572. doi: 10.3390/ijms21155572.
19.         Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med 2015; 88(2): 167–179.
20.         Ramelyte E, Nägeli MC, Hunger R et al. Swiss recommendations for cutaneous basal cell carcinoma. Dermatology 2023; 239(1): 122–131. doi: 10.1159/000526478.
21.         Peris K, Fargnoli MC, Kaufmann R et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer 2023; 192: 113254. doi: 10.1016/j.ejca.2023.113254.
22.         Guedes Neto HJ, Kuramoto DAB, Correia RM et al. What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review. Sao Paulo Med J 2022; 140(2): 320–327. doi: 10.1590/1516-3180.2021.0374.R2.15092021.
23.         Kim JH, Lam JM. Paediatrics: how to manage infantile haemangioma. Drugs Context 2021; 10: 2020-12-6. doi: 10.7573/dic.2020-12-6.
24.         Wollina U, Langner D, França K et al. Pyogenic granuloma – a common benign vascular tumor with variable clinical presentation: new findings and treatment options. Open Access Maced J Med Sci 2017; 5(4): 423–426. doi: 10.3889/oamjms.2017.111.
25.         Crisan D, Gheuca Solovastru L, Crisan M et al. Cutaneous histiocytoma – histological and imaging correlations. A case report. Med Ultrason 2014; 16(3): 268–270.
26.         Kim CC, Swetter SM, Curiel-Lewandrowski C et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: pigmented lesion subcommittee consensus statement. JAMA Dermatol 2015; 151(2): 212–218. doi: 10.1001/jamadermatol.2014.2694.
MUDr. Ondřej Troup
Oddělení plastické chirurgie
FN Plzeň
alej Svobody 80
323 00 Plzeň-Lochotín
troupo@fnplzen.cz
ORCID autorů
O. Troup 0000-0002-6133-2100
V. Woznica 0000-0001-6991-7173
I. Třešková 0000-0003-1440-0120
Labels
Surgery Orthopaedics Trauma surgery
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#